399 related articles for article (PubMed ID: 35130899)
1. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
[TBL] [Abstract][Full Text] [Related]
3. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
[TBL] [Abstract][Full Text] [Related]
4. Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
Dong X; Tsang CCS; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
Explor Res Clin Soc Pharm; 2021 Sep; 3():. PubMed ID: 35434697
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.
Dong X; Tsang CCS; Zhao S; Browning JA; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Hines LE; Wang J
Curr Med Res Opin; 2021 Sep; 37(9):1581-1588. PubMed ID: 34039232
[TBL] [Abstract][Full Text] [Related]
8. Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.
Dong X; Tsang CCS; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Browning JA; Garuccio J; Zeng R; Wang J
Explor Res Clin Soc Pharm; 2024 Mar; 13():100420. PubMed ID: 38420610
[TBL] [Abstract][Full Text] [Related]
9. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.
Wang J; Surbhi S; Zhang Z; Spivey CA; Chisholm-Burns M
Res Social Adm Pharm; 2014; 10(6):904-917. PubMed ID: 25458405
[TBL] [Abstract][Full Text] [Related]
10. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.
Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC
Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.
Lu D; Qiao Y; Johnson KC; Wang J
J Asthma; 2017 Jun; 54(5):504-513. PubMed ID: 27676212
[TBL] [Abstract][Full Text] [Related]
12. Historical trend of disparity implications of Medicare MTM eligibility criteria.
Wang J; Qiao Y
Res Social Adm Pharm; 2013; 9(6):758-69. PubMed ID: 23062785
[TBL] [Abstract][Full Text] [Related]
13. Racial and ethnic disparities in the enrolment of medicare medication therapy management programs.
Garuccio J; Tsang CCS; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Browning JA; Zeng R; Wang J
J Pharm Health Serv Res; 2023 Jun; 14(2):188-197. PubMed ID: 37337596
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.
Browning J; Tsang CCS; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Wang J
J Am Pharm Assoc (2003); 2022; 62(1):142-149. PubMed ID: 34509379
[TBL] [Abstract][Full Text] [Related]
15. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
Wang J; Brown LM; Hong SH
J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
[TBL] [Abstract][Full Text] [Related]
16. Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.
Dong X; Tsang CCS; Browning JA; Sim Y; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J
Curr Med Res Opin; 2023 Jul; 39(7):963-971. PubMed ID: 37219396
[TBL] [Abstract][Full Text] [Related]
17. Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.
Wang J; Qiao Y; Shih YC; Jamison JJ; Spivey CA; Li L; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
Am Health Drug Benefits; 2014 Sep; 7(6):346-58. PubMed ID: 25558303
[TBL] [Abstract][Full Text] [Related]
18. Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.
Wang J; Qiao Y; Tina Shih YC; Spivey CA; Dagogo-Jack S; Wan JY; White-Means SI; Cushman WC; Chisholm-Burns MA
J Pharm Health Serv Res; 2014 Jun; 5(2):109-118. PubMed ID: 25045406
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.
Spivey CA; Qiao Y; Wang J; Shih YT; Wan JY; Dagogo-Jack S; Cushman WC; Hines LE; Chisholm-Burns MA
J Am Geriatr Soc; 2019 Mar; 67(3):581-587. PubMed ID: 30674080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
